Infliximab: additional safety data from an open label study

J Rheumatol. 2002 Apr;29(4):647-9.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / drug therapy*
  • Clinical Trials as Topic*
  • Heart Failure / etiology
  • Humans
  • Infliximab
  • Infusions, Intravenous / adverse effects
  • Opportunistic Infections / etiology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab